Dose-finding study of weekly docetaxel, epirubicin and capecitabine, as first-line treatment in advanced breast cancer

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 2, 2009, Pages 407-412

  Waters, S H ^a   Gillibrand, A ^a   Berry, H ^a   Kumar, S ^a   Velikova, G ^a   Dodwell, D J ^a   Perren, Timothy J ^a  

^a ST JAMES S INSTITUTE OF ONCOLOGY   (United Kingdom)

Author keywords

Anthracyclines; Antineoplastic combined chemotherapy protocols; Breast neoplasms; Capecitabine; Taxoids

Indexed keywords

AMOXICILLIN; CAPECITABINE; CLARITHROMYCIN; DOCETAXEL; EPIRUBICIN; FLUOROURACIL;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CATHETER COMPLICATION; CLINICAL TRIAL; DIARRHEA; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MULTIPLE CYCLE TREATMENT; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; THROMBOCYTOPENIA; TRANSAMINITIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BREAST NEOPLASMS; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; INFUSIONS, INTRAVENOUS; LIVER NEOPLASMS; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TAXOIDS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349120273     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1021-x     Document Type: Article

References (20)

1. IE Smith RP A'Hern GA Coombes 2004 A novel continuous infusional 5-fluorouracil-based chemotherapy regimen compared with conventional chemotherapy in the neo-adjuvant treatment of early breast cancer: 5 year results of the TOPIC trial Ann Oncol 15 751 758 (Pubitemid 38714736)
2. AC Humphreys J Dent S Rodwell 2004 Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study Br J Cancer 90 2131 2134 (Pubitemid 38869716)
3. FA Greco 1999 Docetaxel (Taxotere) administered in weekly schedules Semin Oncol 26 28 31 (Pubitemid 29383335)
4. JD Hainsworth HA Burris 3rd JB Erland 1998 Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer J Clin Oncol 16 2164 2168 (Pubitemid 28265054)
5. JD Hainsworth HA Burris 3rd FA Greco 1999 Weekly administration of docetaxel (Taxotere): summary of clinical data Semin Oncol 26 19 24 (Pubitemid 29368113)
6. D Belotti V Vergani T Drudis 1996 The microtubule-affecting drug paclitaxel has antiangiogenic activity Clin Cancer Res 2 1843 1849 (Pubitemid 26384151)
7. P Nadella C Shapiro GA Otterson 2002 Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies J Clin Oncol 20 2616 2623 (Pubitemid 34575633)
8. N Sawada T Ishikawa Y Fukase 1998 Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts Clin Cancer Res 4 1013 1019 (Pubitemid 28183404)
9. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 31 41
10. P Therasse SG Arbuck EA Eisenhauer 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216
11. J O'Shaughnessy D Miles S Vukelja 2002 Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results J Clin Oncol 20 2812 2823 (Pubitemid 34651510)
12. Beslija S, Obralic N, Basic H et al (2006) Randomized trial of sequence vs. combination of capecitabine (X) and docetaxel (T): XT vs. T followed by X after progression as first-line therapy for patients (pts) with metastatic breast cancer (MBC). J Clin Oncol 24: Suppl 18S, abstract 571
13. Soto C, Torrecillas L, Reyes S et al (2006) Capecitabine (X) and taxanes in patients (pts) with anthracycline-pretreated metastatic breast cancer (MBC): sequential vs. combined therapy results from a MOSG randomized phase III trial. J Clin Oncol 24: Suppl 18S, abstract 570
14. O Pagani C Sessa F Nole 2005 Dose-finding study of weekly docetaxel, anthracyclines plus fluoropyrimidines as first-line treatment in advanced breast cancer Ann Oncol 16 1609 1617 (Pubitemid 41510134)
15. M Venturini A Durando O Garrone 2003 Capecitabine in combination with docetaxel and epirubicin in patients with previously untreated, advanced breast carcinoma Cancer 97 1174 1180 (Pubitemid 36237301)
16. Mansutti M, Fasola G, Cavazzini G et al (2004) Randomized phase III trial comparing TEX (docetaxel, epirubicin and capecitabine) vs. TE (docetaxel, epirubicin) in advanced breast cancer patients: findings from the 2nd interim analysis. Ann Oncol 15:iii42 (abstract 157P)
17. C Wenzel R Bartsch GJ Locker 2005 Preoperative chemotherapy with epidoxorubicin, docetaxel and capecitabine plus pegfilgrastim in patients with primary breast cancer Anticancer Drugs 16 441 445 (Pubitemid 40434610)
18. IF Tannock R de Wit WR Berry 2004 Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N Engl J Med 351 1502 1512 (Pubitemid 39315317)
19. M Di Maio F Perrone P Chiodini 2007 Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer J Clin Oncol 25 1377 1382 (Pubitemid 46706885)
20. F Di Costanzo S Gasperoni P Papaldo 2006 Weekly paclitaxel plus capecitabine in advanced breast cancer patients: dose-finding trial of GOIRC and GOL Ann Oncol 17 79 84 (Pubitemid 43033844)